Effect of Vitamin D Supplement on Vulvovaginal Atrophy of the Menopause

Abstract

The effects of oral vitamin D supplements on vaginal health in postmenopausal women with vulvovaginal atrophy (VVA) was evaluated. A double-blinded, randomized placebo-controlled trial was conducted for 12 weeks to investigate changes on vaginal maturation index (VMI), vaginal pH, and the visual analog scale (VAS) of VVA symptoms. The vitamin D group received oral ergocalciferol, at 40,000 IU per week, while the placebo group received an identical placebo capsule. Eighty postmenopausal women were enrolled. There were no significant differences in baseline characteristics between both groups. In an intention-to-treat analysis, VMI, vaginal pH, and VAS of VVA symptoms showed no significant differences between both groups at the six and 12 weeks. However, the mean difference of VMI in the vitamin D group between baseline and at six weeks showed significant improvement (5.5 + 16.27, p <0.05). Moreover, the mean vaginal pH and VAS of VVA patients in the vitamin D group were significantly improved at both six and 12 weeks compared to baseline. The oral vitamin D supplementation for 12 weeks potentially improves vaginal health outcomes in postmenopausal women with VVA symptoms, demonstrated by the improved mean VMI, vaginal pH, and VAS at six and 12 weeks between baseline, however, no significant differences were observed from the placebo treatment.

The Role of Vitamin D in the Relationship Between Gender and Deep Vein Thrombosis Among Stroke Patients

“…Previous research has shown that vitamin D deficiency was more common in elderly, middle-aged, and perimenopausal females ( 24 , 25 , 33 ). According to a retrospective cohort study, as high as 43.9% of elderly females had vitamin D insufficiency ( 34 ). Decreased serum levels of vitamin D led to reduced calcium absorption and osteoporosis, which is prevalent among perimenopausal women ( 33 ).…”

Effect of vitamin D supplementation on the severity of stress urinary incontinence in premenopausal women with vitamin D insufficiency: a randomized controlled clinical trial

“…This contradiction in results may be due to differences in the age range of the participants. Furthermore, as demonstrated by Kamronrithisorn et al, the effects of vitamin D supplementation may depend on patients’ baseline vitamin D levels, type of vitamin D supplements, and duration of supplementation [ 25 ].…”

Vitamin D in 2020: An Old Pro-Hormone with Potential Effects beyond Mineral Metabolism

“…This last study emphasizes the safety of vitamin D treatment (400-800 IU/day) on calciuria and on the evolution of stones in the urinary tract in these children [15]. In post-menopausal women, ergocalciferol 40,000 IU/week did not change vulvovaginal atrophy compared to placebo, but improved vaginal pH and visual analog scale of vulvovaginal atrophy symptoms between baseline and 12 weeks in the vitamin D group [16]. In very old adults, 25OHD concentrations below 25 nmol/L were associated with moderate and severe disability trajectories, even after adjustment for sex, living in an institution, season, cognitive status, body mass index and vitamin D supplementation [17].…”